Nicholas Manusos

Nicholas Manusos is Chief Executive Officer of Ryne Bio. Recently as President & CEO of Opsis Therapeutics he led the company through a $70MM upfront/funding Strategic R&D Alliance with Bayer-BlueRock Therapeutics, and as COO of Iota Biosciences resulting in a $300MM acquisition by Astellas. Previously held roles include COO of FUJIFILM Cellular Dynamics Inc. and their board observer seat at Century Therapeutics; as VP, Global Head of Business Development at Baxter International Inc.; as VP, Licensing & Business Development at Takeda Pharmaceuticals; and in executive positions at Abbott Laboratories. Nick received his MBA from Northwestern University, J.L. Kellogg Graduate School of Management and his BBA, Operations Management from University of Wisconsin.